June 2026
ASA Center for Anesthesiology and Perioperative Economics (CAPE)
Download Policy Brief: Assessing CMS' Ambulatory Specialty Model (PDF)
The Centers for Medicare and Medicaid Services’ (CMS) Ambulatory Specialty Model (ASM) is a five‑year mandatory payment model starting in January 2027 that aims to hold specialists treating low back pain and heart failure responsible for cost and quality of care. Specialists are selected for participation based on a minimum volume threshold attributed to the respective episode-based cost measure, as well as geographic location. ASM is based on the Merit-Based Incentive Payment System (MIPS) framework and includes maximum payment adjustments of -9/+9% in the first year that increase to -12/+12 by the model’s final year.
Key Findings
After conducting analyses based on CMS data and interviews with anesthesiologists expected to participate in ASM, CAPE concluded that:
Policy Recommendations
CAPE analysis demonstrates a need for CMS to further refine the model and its rules prior to implementation in 2027. CMS should reduce administrative burden and more accurately reflect anesthesiologist and pain medicine workflows by:
Practice Recommendation
The Centers for Medicare and Medicaid Services’ (CMS) Ambulatory Specialty Model (ASM) is an Innovation Center model that aims to hold specialists accountable for cost and quality of care while improving chronic disease management.1 The mandatory model is set to run from January 2027 through December 2031 and includes select anesthesiologists and pain medicine physicians in its low back pain cohort.2
ASM uses the Merit-Based Incentive Payment System (MIPS) framework, with the Quality and Cost categories scored at 50% each and the Improvement Activities (IA) and Promoting Interoperability (PI) categories functioning only as penalties if requirements are not met. Participation in ASM’s low back pain cohort occurs at the individual physician level and is limited to select geographic areas, with CMS applying a volume minimum of 20 episodes a year attributed to the episode-based cost measure for low back pain.1
Physician and practice financial risk is substantial for ASM, and the model’s structure indicates a high likelihood for expansion. Potential payment adjustments start at -9%/+9% and climb to -12/+12% in the model’s final year. These payment adjustments occur two years after each respective performance year and are applied to a participant’s total Medicare B revenue. Unlike MIPS, which provides clinicians with a known threshold to target for a neutral or positive adjustment, ASM will not publish benchmarks in advance.3 This leaves participants with limited ability to gauge their performance in advance or target areas for improvement.
Although ASM allows for positive payouts, CMS will withhold 15% of all incentive payments as savings to the Medicare program.3 While discounts and shared savings mechanisms are common across payment models, they are traditionally linked to care delivery transformation, allowing both participants and Medicare to share in savings gained through value-based care initiatives. However, the ASM withhold represents a direct cut to payments not tied to care transformation. This design also increases the likelihood that the model will qualify for expansion, as it almost guarantees Medicare savings, even in the absence of meaningful transformation in care delivery.
ASM is set to result in significant administrative burden for anesthesiologists, pain medicine physicians, and physician practices. Yet CMS does not provide any financial support or incentives for participants confronting significant implementation costs. By CMS’ calculations, ASM will result in over $100 million in total administrative costs. A CAPE analysis found this figure to be an underestimation, since it does not account for many of the upfront costs associated with the model.
CMS’ Projected Administrative Costs
| Administrative Costs Per Participant | Administrative Costs – All Participants (6,637 Total)2 | |
| Per year | $3,077 | $20,424,438 |
| Model Duration (Five Years) | $15,387 | $102,122,192 |
Source: Analysis by ASA CAPE based on projections from the CMS 2026 Physician Fee Schedule Final Rule.3 CAPE used CMS’ projected administrative costs per ASM participant per year to calculate total projected costs for all participants over the model period. Values were calculated using unrounded figures but are presented rounded to the nearest dollar.
CMS’ substantial ASM administrative burden projection of $102,122,192 is a significant underestimation.
Upfront costs will likely also be higher than expected for ASM participants with experience in MIPS. CAPE found that the majority of ASM participants with MIPS experience used the group-reporting option instead of the individual reporting option that is required under ASM.4 ASM also includes mandatory quality measures, a significant deviation from MIPS, which allows for measure selection.1 ASM’s individual-reporting requirement, mandatory quality measures, and lack of special statuses make it likely that new workflows, technology, and roles might be needed even for those who already participate in MIPS.
Recommendation: To reduce ASM’s administrative burden, CMS should expand the ASM measure set in the low back pain cohort to include a greater number of anesthesia and pain-related quality measures and allow for measure selection. Allowing participants to choose which measures already align with their workflows will decrease costs associated with operationalizing new measures.
Anesthesia and Pain Medicine practices may require additional financial support to implement ASM.
Recommendation: CMS should provide a longer, more expansive preparation period by reducing early-year penalties and giving participants access to historical performance benchmarks on ASM quality and cost measures. CMS should also provide financial support for affected practices, similar to other Innovation Center Models. Incorporating a more robust preparation period ensures that physicians are not constrained by both high upfront administrative costs and significant downside risk while trying to operationalize the model.
ASM’s high administrative costs may create barriers to meaningful participation among required participants and could increase consolidation across the healthcare landscape.
ASM does not honor special statuses, which departs from the established MIPS framework. A CAPE analysis concludes that over two-thirds of anesthesiologists in ASM would likely qualify for MIPS special statuses, undermining CMS’ argument that special statuses would not be applicable for selected ASM participants.3
Qualification for PI Exemption Based on Special Status by Medical Specialty – Low Back Pain Cohort
| Specialty | Count of ASM ParticipantsI | Qualified for PI Reweighting Based on Special StatusII | |
| count | percent of total | ||
| Anesthesiology | 377 | 260 | 69.0% |
| Interventional Pain Management | 285 | 191 | 67.0% |
| Pain Management | 448 | 235 | 52.50% |
| Neurosurgery | 199 | 85 | 42.7% |
| Orthopedic Surgery | 700 | 210 | 30.0% |
| Physical Medicine and Rehabilitation | 572 | 227 | 39.7% |
Source: Analysis by ASA CAPE based on the 2024 Quality Payment Program (QPP) Public Use File (PUF).4
I. Includes all Tax Identification Numbers-National Provider Identifiers (TINs-NPIs) from the 2024 QPP PUF associated with ASM Participant NPIs.
II. Count of physicians who had at least one special status (i.e., small practice, hospital-based, non-patient facing, Ambulatory Surgery Center (ASC) based) that qualified them for automatic reweighing of the PI performance category in MIPS for 2024.
Recommendation: For CMS policies to be effective and fair, ASM must include MIPS special status protections that exempt non-patient-facing, small-practice, hospital-based, and Ambulatory Surgery Center (ASC) based clinicians from reporting PI. These protections align ASM with MIPS and ensure that PI does not inappropriately affect performance assessments for anesthesiologists who have limited ability to meaningfully engage with this performance category.
CAPE’s evaluation of ASM indicates that the model will result in significant physician and practice burden while failing to engage anesthesiologists and pain medicine physicians in the meaningful care transformation that drives value in healthcare. Anesthesiologists and pain medicine physicians want to be incorporated into alternative payment models that decrease healthcare costs while improving care quality. CMS should actively and transparently engage with specialists as a partner to innovation and avoid unnecessarily burdensome requirements. Future specialist-specific model development would greatly benefit from early conversations between the CMS Innovation Center and specialty associations. Early conversations between the ASA and the CMS Innovation Center would promote buy-in while ensuring that models reflect clinical workflows and minimize physician burden.
Suggested Citation:
Center for Anesthesia Perioperative Economics. Assessing CMS’ Ambulatory Specialty Model: Policy Recommendations to Reduce Administrative Burden for Anesthesiologists and Pain Medicine Physicians. Schaumburg, IL: American Society of Anesthesiologists; June 2026.
Date of last update: June 23, 2026